New fund · Financial Services

Skegen Asset Management plans second fund of up to ₹5,000 crore

By Startup Enthusiast · 25 August 2026

What they do

Skegen Asset Management is an investment firm that focuses exclusively on manufacturing companies rather than the services sector

The firm is planning to raise a second fund targeting between ₹3,000 crore and ₹5,000 crore to expand its portfolio

The firm differentiates itself by providing patient capital with a 10-year lifespan and strategic support to help companies scale operations

Skegen Asset Management is preparing to launch its second fund with a target corpus of ₹3,000 to ₹5,000 crore.
The firm is shifting its strategy to include institutional investors for this new fund while keeping the promoter family as the largest partner.
The firm's first fund, which is nearing completion, raised approximately ₹2,500 crore from the Bharat Biotech promoter family.
Skegen maintains a 10-year fund life, allowing it to take a patient approach without immediate pressure to exit investments.
The firm invests in first-generation, promoter-driven companies and typically acquires a 10% to 25% stake in these businesses.

The firm adopts a contrarian approach by focusing on manufacturing enterprises in an Indian market that is heavily skewed toward services.
Skegen leverages the global reach of the Bharat Biotech network, which spans 120 markets, to provide growth opportunities for its portfolio companies.
The firm retains majority equity in its portfolio companies even after they go public to capitalize on long-term growth.

Skegen invests in deep-tech, consumer, and manufacturing enterprises that demonstrate an innovative competitive advantage.
The firm provides support beyond capital, including financial discipline, business development, and operational guidance.
It currently manages $300 million in assets across seven different sectors.
Portfolio companies include Midwest Ltd, Sagar Defence Engineering, Raghu Vamsi Machine Tools, Continental Coffee, Dodla, and Eastman.
The firm is registered with SEBI as a Category II Alternative Investment Fund.

Bharat Biotech promoter family (lead) — The founding family of the vaccine manufacturer Bharat Biotech.